Pharmaceutical giant turns to Clifford Chances and Ropes & Gray for deal to boost its product portfolio
February 06, 2015 at 06:19 AM
1 minute read
The original version of this story was published on Legalweek
Clifford Chance, Ropes & Gray and Skadden Arps Slate Meagher & Flom have been called up as advisers for Pfizer’s $17bn (£11bn) acquisition of injectable drugmaker Hospira.
The pharmaceutical giant announced yesterday that its offer of $90 (£59) a share had been unanimously approved by the boards of both companies.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
